We present a 33-year-old woman with anti-U1 ribonucleoprotein antibody positive mixed connective tissue disease (MCTD) since the age of 13. Predominant features were of inflammatory arthritis, Raynaud ...

Sometimes called “overlap disease,” people with a mixture of symptoms from several different diseases may have what’s known as mixed connective tissue disease.

The MosaiQ AiPlex CTDplus assay enables a syndromic approach and accurate serological evaluation of Rheumatoid Arthritis (RA) and systematic connective tissue diseases (CTD) for healthcare providers.

Today, AliveDx announces it has submitted 510 (k) premarket notification to the U.S. Food and Drug Administration (FDA) for the MosaiQ AiPlex® Connective Tissue Diseases (CTDplus) microarray. The ...

For connective tissue diseases, the multiplex assay is designed to rapidly detect and identify up to 1275 disease markers per hour. Seamless, microarray-internal calibration and quality control as ...

The incidence of all musculoskeletal symptoms and connective-tissue diseases was similar in both the group authenticated by biopsy and the group not so studied.

Multiplex testing provides a comprehensive autoantibody profile and helps reducing time to diagnosis. The MosaiQ AiPlex CTDplus assay enables a syndromic approach and accurate serological evaluation ...

AliveDx’s MosaiQ AiPlex CTDplus multiplex assay receives IVDR-CE mark to aid in diagnosing systemic autoimmune rheumatic diseases and streamline laboratory workflow ...

The MosaiQ AiPlex CTDplus assay enables a syndromic approach and accurate serological evaluation of Rheumatoid Arthritis (RA) and connective tissue diseases (CTD) for healthcare providers.